These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23436807)

  • 1. Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa.
    Nagant C; Pitts B; Stewart PS; Feng Y; Savage PB; Dehaye JP
    Microbiologyopen; 2013 Apr; 2(2):318-25. PubMed ID: 23436807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
    Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa.
    Nagant C; Feng Y; Lucas B; Braeckmans K; Savage P; Dehaye JP
    J Appl Microbiol; 2011 Sep; 111(3):763-72. PubMed ID: 21699631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.
    Manavathu EK; Vager DL; Vazquez JA
    BMC Microbiol; 2014 Mar; 14():53. PubMed ID: 24588809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antimicrobial Peptide Gad-1 Clears Pseudomonas aeruginosa Biofilms under Cystic Fibrosis Conditions.
    Portelinha J; Angeles-Boza AM
    Chembiochem; 2021 May; 22(9):1646-1655. PubMed ID: 33428273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and antibiofilm activities of ceragenins against
    Damar-Çelik D; Mataracı-Kara E; Savage PB; Özbek-Çelik B
    J Chemother; 2021 Jul; 33(4):216-227. PubMed ID: 32985386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
    Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.
    Aaron SD; Ferris W; Ramotar K; Vandemheen K; Chan F; Saginur R
    J Clin Microbiol; 2002 Nov; 40(11):4172-9. PubMed ID: 12409393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma.
    Alkawareek MY; Algwari QT; Laverty G; Gorman SP; Graham WG; O'Connell D; Gilmore BF
    PLoS One; 2012; 7(8):e44289. PubMed ID: 22952948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
    Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
    Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.